Glaxo Group Ltd v Genentech Inc & Anor
The balance of justice favours allowing UK proceedings to go to trial rather than granting a stay pending EPO opposition, due to the risk of significant delay, prejudice to commercial certainty, and insufficient mitigation by the undertakings offered. The presumption in favour of a stay is not strong and is outweighed by the need for timely resolution.
- Parties
- Claimant: Glaxo Group Limited; Defendant: Genentech Inc; Defendant: Biogen Idec Inc
- Jurisdiction
- England and Wales
- Judgment Date
- 15 June 2007
- Procedural Posture
- Patent Revocation / Interlocutory Application for Stay
- Outcome
- Application for stay refused
- Legal Topics
- Stay of Proceedings, Parallel Litigation, Forum Non Conveniens, Patent Revocation, EPO Opposition, Commercial Certainty
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Glaxo Group Limited
Claimant
Genentech Inc
Defendant
Biogen Idec Inc
Defendant
Procedural Posture
Patent Revocation / Interlocutory Application for Stay
Legal Issues
- 1 Should UK patent revocation proceedings be stayed pending EPO opposition outcome?
- 2 Is there a presumption in favour of a stay in patent cases with parallel EPO proceedings?
- 3 Does absence of infringement proceedings affect the stay analysis?
Ratio Decidendi
The balance of justice favours allowing UK proceedings to go to trial rather than granting a stay pending EPO opposition, due to the risk of significant delay, prejudice to commercial certainty, and insufficient mitigation by the undertakings offered. The presumption in favour of a stay is not strong and is outweighed by the need for timely resolution.
Court Disposition
Application for stay refused
Orders
- UK patent revocation proceedings to proceed to trial
- No stay pending EPO opposition
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment